Cargando…
Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Despite numerous studies in the field of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, some clinical variability of the presentation and discrepancies in the genotype/phenotype correlation are still unexplained. Some, but not all, discordant phenotypes caused by mutations wi...
Autores principales: | Kocova, Mirjana, Anastasovska, Violeta, Falhammar, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392929/ https://www.ncbi.nlm.nih.gov/pubmed/32367336 http://dx.doi.org/10.1007/s12020-020-02323-3 |
Ejemplares similares
-
Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Kocova, Mirjana, et al.
Publicado: (2022) -
Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up
por: Kocova, Mirjana, et al.
Publicado: (2018) -
Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency
por: Anastasovska, Violeta, et al.
Publicado: (2015) -
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020) -
Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2020)